Champions Oncology Operating Income

Champions Oncology (CSBR) currently reports a operating income of $-1.2M as of April 2026. That compares with $4.6M in the prior-year period — down 127.4% year over year. Use the charts on this page to explore Champions Oncology's operating income history and peer comparisons.

Champions Oncology's operating income decreased from $4.6M to $-1.2M — a 127.4% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Champions Oncology reported $-1.2M in operating income as of April 2026. That compares with $4.6M in the prior-year period — down 127.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-1.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Champions Oncology, and consider following CSBR for alerts when major investors trade the stock.

Champions Oncology is classified in the Healthcare sector. On operating income, it currently shows $-1.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSBR with unrelated industries.